AKT1 and neoplasm: Moreover, bioinformatics and experimental analyses of the expression profile of ESCA cells lacking CD155 suggested that CD155 downstream effects are mediated by the PI3K/Akt and MAPK signaling pathways, which are known to be involved in tumor proliferation [33,34,35].